Gastropathy by nonsteroidal anti-inflammatory drugs and its association with Helicobacter pylori;Gastropatía por antiinflamatorios no esteroideos y su asociación con Helicobacter pylori

Revista de Investigacion Clinica

Volumn 55, Issue 3, 2003, Pages 254-259

  Rodríguez Hernández, Heriberto ^a,b   Jacobo Karam, Janett S ^b,c   Jáquez Quintana, Joel O ^b   Avila Romero, Hilda G ^b   Galván Román, Liliana ^b   Lara Miranda, Sandra C ^b   Sánchez Anguiano, Luis F ^b  

^a Hospital General Regional No 1   (Mexico)

^b UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^c Hospital General de la SSA   (Mexico)

Author keywords

Duodenal ulcer; Gastric ulcer; Gastropathy; Helicobacter pylori; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER BLEEDING; RISK FACTOR; STOMACH DISEASE; TOBACCO; UPPER GASTROINTESTINAL BLEEDING;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-SECTIONAL STUDIES; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MEXICO; MIDDLE AGED; RISK FACTORS;

EID: 0042914700     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Larkai EN, Smith JL, Lisky MD, Graham DY. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronical steroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 82: 1153-8.
2. Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study. Arch Intern Med 1996; 156: 1530-6.
3. Griffin MR, Piper JM, Daugherty JR. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly person. Ann Intern Med 1991; 114: 257-63.
4. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999; 340: 1888-99.
5. Ballesteros MA. Ulcera péptica y Helicobacter pylori. Resultados y consecuencias de su erradicación. Rev Gastroenterol Mex 2000; 65: 41-9.
6. Hawkey CJ. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 2000; 119: 521-35.
7. Lancaster-Smith MJ, Jaderberg ME, Jackson DA. Ranitidine in the treatment of non-steroidal anti-inflammatory drug-associated gastric and duodenal ulcers. Gut 1991; 32: 2582-5.
8. Hawkey CJ. Nonsteroidal anti-inflammatory drugs and peptic ulcers. Facts and figures multiply, but do they add up? BMJ 1990; 300: 278-84.
9. Weil J, Langman MJS, Wainwrigth P, Lawson DH, Rawlins M, Logan RFA, Browen TP, et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000; 46: 27-31.
10. Stack WA, Hawkey GM, Atherton JC, Logan RF, Hawkey CJ. Interactions of risk factors for peptic ulcer bleeding (abst). Gastroenterology 1999; 116: A97.
11. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 2001; 120: 594-606.
12. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to the use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115: 787-96.
13. Márquez-Murillo MN, Suazo J, Poo JL. Gastropatía por anti-inflamatorios no esteroideos. Rev Invest Clin 1997; 49: 241-54.
14. Graham DY, Smith L.I. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol 1988; 83: 1081-4.
15. Di Mario F, Leandro G, Battaglia G, Pilotto A, del Santo P, Vianello F, Franceshi M et al. Do concomitant disease and therapies affect the persistence of ulcer symptoms in the elderly? Dig Dis Sci 1996; 41: 17-21.
16. Graham DY, White RH, Moreland LW, et al. Duodenal and gastric ulcer prevention with misoprostol in arthritic patients taking NSAIDs. Ann Intern Med 1993; 119: 257-62 .
17. Langman MJS. Epidemilogic evidence on the association between peptic ulceration and anti-inflammatory drug use. Gastroenterology 1989; 96: 640-6.
18. Segal WN, Cello JP. Hemorrhage in the upper gastrointestinal tract in the older patient. Am J Gastroenterol 1997; 92: 42-6.
19. O'Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med 1998; 338: 592-602.
20. Farrell JJ, Friedman LS. Gastrointestinal bleeding in older people. Gastroenterol Clin North Am 2000; 29: 1-36.
21. García-Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-72.
22. Battaglia G, Di Mario F, Leandro G, Pilotto A, Ferrano A, Vianello F, et al. Markers of slow-healing peptic ulcer in the elderly. A study on 1052 ranitidine-treated patients. Dig Dis Sci 1993; 38: 1414-21.
23. Chan FKL, Sung JJY, Chung SC, To KF, Yung MY, Leung VKS, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975-9.
24. Graham DY, Lidsky MD, Cox AM, Evans DJ, Alpert L, Klein PD. Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology 1991; 100: 1653-7.
25. Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Gastroenterology 1999; 116: 1305-9.
26. Langman MJ, Weil J, Wainwrigth P. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-8.
27. Graham DY. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: Where we stand. Am J Gastroenterol 1996; 91: 2080-6.
28. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, Murphy M, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-8.
29. Hawkey CJ, Tulassay Z, Szczepanski L, van Rensburg CJ, Fillipowicz-Sosnowska A, Lanas A, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal-antinflammatory drugs: HELP NSAIDs study. Helicobacter eradication por lesion prevention. Lancet 1998; 352: 1016-21.
30. Chan FK, Chung SC, Suen BY. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 967-73.
31. Chan HLY, Wu JCH, Chan FK, Choi CHL, Ching JYL, Lee YT, et al. Is non Helicobacter pylori, non NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 997 patients. Gastrointest Endosc 2001; 53: 438-42.
32. Scheiman JM, Bandekar RR, Chernew ME, Fendrick AM. Helicobacter pylori screening for individuals requiring chronic NSAID therapy: a decision analysis. Aliment Pharmacol Ther 2001; 15: 63-71.
33. Chan FKL, To KF, Wu JCY, Yung MY, Leung WK, Kwok T, et al. Eradication of Helicobacter pylori and risk of peptic ulcer in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002; 359: 9-13.
34. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359: 14-22.
35. Pounder RE. Helicobacter pylori and NSAIDs - the end of the debate? Lancet 2002; 359: 3-4.
36. Laine L. Nonsteroidal anti-inflammatory drug gastropathy. Gastrointest Endosc Clin North Am 1996; 6: 489-504.